BeOne Medicines Ltd. SEC filings ONC
BeOne Medicines Ltd. has 1,002 filings in SEC EDGAR's recent list, going back to Nov 19, 2018. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 26, 2026 | Aug 26, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Other events
|
Jun 26, 2026 | Jun 26, 2026 |
| S-8 | Employee stock plan registration | Jun 11, 2026 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 11, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Other events
|
May 15, 2026 | May 13, 2026 |
| S-3ASR | Automatic shelf registration | May 6, 2026 | — |
| S-3ASR | Automatic shelf registration | May 6, 2026 | — |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 6, 2026 | May 6, 2026 |
| ARS | Annual report to shareholders | Apr 28, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 28, 2026 | — |
| DEF 14A | Proxy statement | Apr 28, 2026 | Jun 11, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 16, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Results of operations
|
Apr 14, 2026 | Apr 14, 2026 |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Agreement ended
|
Dec 19, 2025 | Dec 16, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 18, 2025 | Dec 17, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Nov 19, 2025 | Nov 13, 2025 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 29, 2025 | Aug 29, 2025 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Aug 25, 2025 | Aug 25, 2025 |
| 10-Q | Quarterly report | Aug 6, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 6, 2025 |
| UPLOAD | Letter from the SEC | Jun 18, 2025 | — |
| CORRESP | Letter to the SEC | Jun 10, 2025 | — |
| EFFECT | Filing | Jun 2, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 2, 2025 | — |
| POSASR | Filing | May 27, 2025 | — |
| POSASR | Filing | May 27, 2025 | — |
| POS AM | Filing | May 27, 2025 | — |
| S-8 POS | Filing | May 27, 2025 | — |
| S-8 POS | Filing | May 27, 2025 | — |
| S-8 POS | Filing | May 27, 2025 | — |
| S-8 POS | Filing | May 27, 2025 | — |
| S-8 POS | Filing | May 27, 2025 | — |
| S-8 POS | Filing | May 27, 2025 | — |
| S-8 POS | Filing | May 27, 2025 | — |
| S-8 POS | Filing | May 27, 2025 | — |
| S-8 POS | Filing | May 27, 2025 | — |
| 8-K12G3 | Form 8-k12g3 | May 27, 2025 | May 27, 2025 |
| EFFECT | Filing | May 23, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
May 21, 2025 | May 21, 2025 |
| 8-K |
Current report
Unregistered share sale
|
May 13, 2025 | May 13, 2025 |
| 10-Q | Quarterly report | May 7, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 7, 2025 | May 7, 2025 |
| F-6/A | Filing | May 1, 2025 | — |
| 8-K |
Current report
Other events
|
Apr 29, 2025 | Apr 29, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Apr 28, 2025 | Apr 28, 2025 |
| 8-K |
Current report
Results of operations
|
Apr 28, 2025 | Apr 28, 2025 |
| F-6 | Filing | Apr 24, 2025 | — |
| ARS | Annual report to shareholders | Apr 7, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 7, 2025 | — |
| DEF 14A | Proxy statement | Apr 7, 2025 | May 21, 2025 |
| PRE 14A | Preliminary proxy statement | Mar 27, 2025 | May 21, 2025 |
| DEFA14A | Additional proxy material | Mar 10, 2025 | — |
| 424B3 | Prospectus | Mar 10, 2025 | — |
| EFFECT | Filing | Mar 7, 2025 | — |
| CORRESP | Letter to the SEC | Mar 6, 2025 | — |
| 10-K/A | Amended annual report | Feb 28, 2025 | Dec 31, 2024 |
| S-4/A | Filing | Feb 28, 2025 | — |
| CORRESP | Letter to the SEC | Feb 27, 2025 | — |
| 10-K | Annual report | Feb 27, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2025 | Feb 27, 2025 |
| UPLOAD | Letter from the SEC | Jan 31, 2025 | — |
| CORRESP | Letter to the SEC | Jan 21, 2025 | — |
| S-4/A | Filing | Jan 21, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 10-K/A | Amended annual report | Jan 8, 2025 | Dec 31, 2023 |
| 8-K |
Current report
Other events
|
Dec 23, 2024 | Dec 23, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Dec 10, 2024 | Dec 9, 2024 |
| 8-K |
Current report
Other events
|
Nov 19, 2024 | Nov 14, 2024 |
| 8-K |
Current report
Other events
|
Nov 14, 2024 | Nov 14, 2024 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Other events
|
Oct 28, 2024 | Oct 25, 2024 |
| CORRESP | Letter to the SEC | Oct 24, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 18, 2024 | — |
| 8-K |
Current report
Other events
|
Sep 30, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 26, 2024 | Sep 25, 2024 |
| UPLOAD | Letter from the SEC | Sep 5, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 3, 2024 | — |
| 8-K |
Current report
Results of operations
|
Aug 29, 2024 | Aug 29, 2024 |
| CORRESP | Letter to the SEC | Aug 21, 2024 | — |
| S-4 | Registration for a merger or exchange | Aug 7, 2024 | — |
| 10-Q | Quarterly report | Aug 7, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 7, 2024 | Aug 7, 2024 |
| CORRESP | Letter to the SEC | Jul 31, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 25, 2024 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 18, 2024 | Jul 17, 2024 |
| S-8 | Employee stock plan registration | Jun 5, 2024 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 5, 2024 | Jun 5, 2024 |
| 10-Q | Quarterly report | May 8, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
May 8, 2024 | May 8, 2024 |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Results of operations
|
Apr 26, 2024 | Apr 26, 2024 |
| 8-K |
Current report
Other events
|
Apr 23, 2024 | Apr 23, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 15, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Mar 20, 2024 | Mar 19, 2024 |
| 8-K |
Current report
Other events
|
Mar 15, 2024 | Mar 14, 2024 |
| 8-K |
Current report
Other events
|
Mar 8, 2024 | Mar 8, 2024 |
| 10-K | Annual report | Feb 26, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Feb 26, 2024 | Feb 26, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 23, 2024 | Jan 22, 2024 |
| 8-K |
Current report
Other events
|
Dec 8, 2023 | Dec 7, 2023 |
| UPLOAD | Letter from the SEC | Dec 7, 2023 | — |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Other events
|
Oct 20, 2023 | Oct 20, 2023 |
| CORRESP | Letter to the SEC | Oct 4, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 21, 2023 | — |
| 8-K |
Current report
Other events
|
Sep 21, 2023 | Sep 19, 2023 |
| 8-K |
Current report
Agreement ended
|
Sep 19, 2023 | Sep 17, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 29, 2023 | Aug 29, 2023 |
| CORRESP | Letter to the SEC | Aug 21, 2023 | — |
| 10-Q | Quarterly report | Aug 2, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Material agreement, Agreement ended, Results of operations, Other events
|
Aug 2, 2023 | Aug 1, 2023 |
| CORRESP | Letter to the SEC | Jul 26, 2023 | — |
| 8-K |
Current report
Other events
|
Jul 24, 2023 | Jul 21, 2023 |
| UPLOAD | Letter from the SEC | Jul 21, 2023 | — |
| 8-K |
Current report
Agreement ended, Other events
|
Jul 11, 2023 | Jul 10, 2023 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results, Other events
|
Jun 15, 2023 | Jun 9, 2023 |
| 8-K |
Current report
Other events
|
May 26, 2023 | May 25, 2023 |
| S-3ASR | Automatic shelf registration | May 9, 2023 | — |
| S-3ASR | Automatic shelf registration | May 9, 2023 | — |
| 8-K |
Current report
Other events
|
May 8, 2023 | May 6, 2023 |
| 10-Q | Quarterly report | May 4, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
May 4, 2023 | May 4, 2023 |
| ARS | Annual report to shareholders | Apr 27, 2023 | Dec 31, 2022 |
| DEF 14A | Proxy statement | Apr 27, 2023 | — |
| 8-K |
Current report
Results of operations
|
Apr 25, 2023 | Apr 25, 2023 |
| 8-K |
Current report
Other events
|
Apr 20, 2023 | Apr 20, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2023 | — |
| 8-K |
Current report
Other events
|
Mar 29, 2023 | Mar 27, 2023 |
| 10-K | Annual report | Feb 27, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations, Other events
|
Feb 27, 2023 | Feb 24, 2023 |
| 8-K |
Current report
Material agreement
|
Jan 31, 2023 | Jan 30, 2023 |
| 8-K |
Current report
Other events
|
Jan 23, 2023 | Jan 18, 2023 |
| 8-K |
Current report
Other events
|
Jan 5, 2023 | Dec 30, 2022 |
| 8-K |
Current report
Other events
|
Dec 19, 2022 | Dec 13, 2022 |
| 8-K |
Current report
Other events
|
Nov 22, 2022 | Nov 17, 2022 |
| 10-Q | Quarterly report | Nov 9, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 9, 2022 | Nov 9, 2022 |
| 8-K |
Current report
Other events
|
Nov 7, 2022 | Nov 2, 2022 |
| 8-K |
Current report
Other events
|
Oct 14, 2022 | Oct 12, 2022 |
| 8-K |
Current report
Other events
|
Sep 22, 2022 | Sep 19, 2022 |
| 8-K |
Current report
Other events
|
Sep 15, 2022 | Sep 10, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 30, 2022 | Aug 30, 2022 |
| 8-K |
Current report
Other events
|
Aug 25, 2022 | Aug 23, 2022 |
| 8-K |
Current report
Other events
|
Aug 10, 2022 | Aug 9, 2022 |
| S-8 | Employee stock plan registration | Aug 8, 2022 | — |
| 10-Q | Quarterly report | Aug 8, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 4, 2022 | Aug 4, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 20, 2022 | Jul 20, 2022 |
| 8-K |
Current report
Other events
|
Jul 15, 2022 | Jul 14, 2022 |
| 8-K |
Current report
Other events
|
Jun 30, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Other events
|
Jun 22, 2022 | Jun 21, 2022 |
| UPLOAD | Letter from the SEC | Jun 15, 2022 | — |
| 8-K |
Current report
Other events
|
Jun 14, 2022 | Jun 10, 2022 |
| CORRESP | Letter to the SEC | Jun 3, 2022 | — |
| 8-K |
Current report
Other events
|
May 27, 2022 | May 26, 2022 |
| UPLOAD | Letter from the SEC | May 20, 2022 | — |
| 10-Q | Quarterly report | May 9, 2022 | Mar 31, 2022 |
| CORRESP | Letter to the SEC | May 6, 2022 | — |
| 8-K |
Current report
Results of operations, Other events
|
May 5, 2022 | May 4, 2022 |
| DEF 14A | Proxy statement | Apr 29, 2022 | Jun 22, 2022 |
| 8-K |
Current report
Results of operations, Other events
|
Apr 28, 2022 | Apr 27, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 20, 2022 | Apr 15, 2022 |
| PRE 14A | Preliminary proxy statement | Apr 18, 2022 | Jun 22, 2022 |
| 8-K |
Current report
Other events
|
Apr 12, 2022 | Apr 6, 2022 |
| CORRESP | Letter to the SEC | Apr 11, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 7, 2022 | — |
| 8-K |
Current report
Auditor change, Other events
|
Mar 25, 2022 | Mar 23, 2022 |
| 8-K |
Current report
Other events
|
Mar 17, 2022 | Mar 11, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 3, 2022 | Mar 2, 2022 |
| 10-K | Annual report | Feb 28, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations, Other events
|
Feb 25, 2022 | Feb 25, 2022 |
| 8-K |
Current report
Other events
|
Feb 22, 2022 | Feb 17, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 16, 2022 | Feb 16, 2022 |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 2, 2022 | Jan 28, 2022 |
| UPLOAD | Letter from the SEC | Jan 28, 2022 | — |
| 8-K |
Current report
Other events
|
Jan 25, 2022 | Jan 20, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 10, 2022 | Jan 6, 2022 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Dec 20, 2021 | Dec 19, 2021 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Dec 17, 2021 | Dec 15, 2021 |
| CORRESP | Letter to the SEC | Dec 17, 2021 | — |
| 8-K |
Current report
Other events
|
Dec 14, 2021 | Dec 10, 2021 |
| 8-K |
Current report
Other events
|
Dec 6, 2021 | Nov 30, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Dec 6, 2021 | Nov 30, 2021 |
| 424B5 | Prospectus supplement | Dec 1, 2021 | — |
| CORRESP | Letter to the SEC | Nov 24, 2021 | — |
| 424B5 | Prospectus supplement | Nov 23, 2021 | — |
| 8-K |
Current report
Other events
|
Nov 23, 2021 | Nov 19, 2021 |
| UPLOAD | Letter from the SEC | Nov 22, 2021 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ONC (Nasdaq), BEIGF (OTC)
- Fiscal year ends
- December 31
- Headquarters
- Basel
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1651308
- Former names
- BeiGene, Ltd. (until May 27, 2025)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.